MUC16 and benign neoplasm: CA-125 levels were significantly higher in patients with malignancy (472.3±544.5U/ml) as compared to healthy controls (24.13±9.6U/ml) (p=0.0026) but there was no significant difference found between patients with malignant tumours and benign tumours (p>0.05) (Fig. 6b).